We further demonstrated that CMTM4 could be used as an independent prognostic factor for poor survival in patients with certain cancer types since the corresponding patient group exhibiting higher expression of CMTM4 had a significantly reduced survival rate when compared to the same cancer type with lower CMTM4 expression (Fig. 1E,F; Appendix Table S1). The gene discussed is CMTM4; the disease is cancer.